Bessemer Group Inc Novo Nordisk A S Transaction History

Bessemer Group Inc

  • $60.7 Billion
  • Q3 2024

A detailed history of Bessemer Group Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Bessemer Group Inc holds 76,931 shares of NVO stock, worth $8.08 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
76,931
Previous 73,397 4.81%
Holding current value
$8.08 Million
Previous $10.5 Million 12.56%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$119.07 - $145.42 $420,793 - $513,914
3,534 Added 4.81%
76,931 $9.16 Million
Q2 2024

Aug 13, 2024
BUY
$122.71 - $146.91 $6,503 - $7,786
53 Added 0.07%
73,397 $10.5 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $786,859 - $1.05 Million
-7,706 Reduced 9.51%
73,344 $9.42 Million
Q4 2023

Feb 09, 2024
BUY
$87.78 - $105.45 $316,710 - $380,463
3,608 Added 4.66%
81,050 $8.38 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $3.71 Million - $8.14 Million
40,769 Added 111.17%
77,442 $7.04 Million
Q2 2023

Aug 10, 2023
SELL
$155.98 - $172.65 $533,451 - $590,463
-3,420 Reduced 8.53%
36,673 $5.94 Million
Q1 2023

May 10, 2023
SELL
$132.34 - $159.14 $148,485 - $178,555
-1,122 Reduced 2.72%
40,093 $6.38 Million
Q4 2022

Feb 13, 2023
BUY
$102.55 - $135.33 $449,784 - $593,557
4,386 Added 11.91%
41,215 $5.58 Million
Q3 2022

Nov 09, 2022
BUY
$95.28 - $116.93 $160,927 - $197,494
1,689 Added 4.81%
36,829 $3.67 Million
Q2 2022

Aug 10, 2022
BUY
$103.24 - $121.81 $1.53 Million - $1.81 Million
14,857 Added 73.25%
35,140 $3.92 Million
Q1 2022

May 12, 2022
SELL
$93.1 - $112.54 $206,030 - $249,051
-2,213 Reduced 9.84%
20,283 $2.25 Million
Q4 2021

Jan 27, 2022
BUY
$95.88 - $117.08 $1.65 Million - $2.01 Million
17,179 Added 323.1%
22,496 $2.52 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $111,772 - $141,164
-1,324 Reduced 19.94%
5,317 $511,000
Q2 2021

Aug 06, 2021
BUY
$67.66 - $84.76 $216,106 - $270,723
3,194 Added 92.66%
6,641 $557,000
Q1 2021

May 13, 2021
SELL
$67.06 - $75.82 $1.9 Million - $2.15 Million
-28,390 Reduced 89.17%
3,447 $232,000
Q4 2020

Feb 09, 2021
BUY
$63.89 - $73.8 $181,511 - $209,665
2,841 Added 9.8%
31,837 $2.22 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $53,117 - $58,563
-834 Reduced 2.8%
28,996 $2.01 Million
Q2 2020

Aug 05, 2020
SELL
$58.54 - $67.94 $66,677 - $77,383
-1,139 Reduced 3.68%
29,830 $1.95 Million
Q1 2020

Apr 30, 2020
BUY
$49.46 - $64.78 $75,228 - $98,530
1,521 Added 5.17%
30,969 $1.87 Million
Q4 2019

Feb 04, 2020
BUY
$49.86 - $58.26 $4,188 - $4,893
84 Added 0.29%
29,448 $1.7 Million
Q3 2019

Nov 07, 2019
SELL
$47.54 - $53.43 $285,667 - $321,060
-6,009 Reduced 16.99%
29,364 $1.52 Million
Q2 2019

Jul 19, 2019
SELL
$46.79 - $52.47 $2,667 - $2,990
-57 Reduced 0.16%
35,373 $1.81 Million
Q1 2019

May 13, 2019
SELL
$46.36 - $52.63 $120,350 - $136,627
-2,596 Reduced 6.83%
35,430 $1.85 Million
Q4 2018

Feb 12, 2019
BUY
$41.54 - $47.25 $25,339 - $28,822
610 Added 1.63%
38,026 $1.75 Million
Q3 2018

Nov 06, 2018
SELL
$46.76 - $51.24 $18,844 - $20,649
-403 Reduced 1.07%
37,416 $1.76 Million
Q2 2018

Jul 25, 2018
SELL
$44.29 - $50.42 $42,296 - $48,151
-955 Reduced 2.46%
37,819 $1.74 Million
Q1 2018

May 10, 2018
BUY
$48.49 - $58.14 $218,883 - $262,443
4,514 Added 13.18%
38,774 $1.91 Million
Q4 2017

Jan 30, 2018
SELL
$47.53 - $53.73 $129,661 - $146,575
-2,728 Reduced 7.38%
34,260 $1.84 Million
Q3 2017

Nov 03, 2017
BUY
$41.15 - $49.22 $1.52 Million - $1.82 Million
36,988
36,988 $1.78 Million

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email